.

Division of Vascular Surgery

Carotid Disease

European Carotid Surgery Trialists’ Collaborative Group, MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991;337:1235–1243.

Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg. 2005;42(2):213-9.

Savitz S, Caplan L. Vertebrobasilar disease. N Engl J Med 2005;352(25):2618-26.

Yadav J, Wholey M, Kuntz R, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–1501

MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-1502.

Barnett H, Taylor D, Eliasziw M, Fox A, Ferguson G, Haynes R, Rankin R, Clagett G, Hachinski V, Sackett D, Thorpe K, Meldrum H, Spence J, for The North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis. NEJM 1998 Nov 12;339(20):1415-1425.

[NASCET].  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. NEJM 1991; 325:445-53.

[ACAS]Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273:1421-28.

This page was last updated July 25, 2013 and is maintained by